A randomized, open label, crossover study to explore drug-drug interactions between DWC20155 / DWC20156 and DWC20163 in Healthy Volunteers
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
52
Maximum Plasma Concentration (Cmax)
Time frame: 0 ~ 24 hours
Area under the time versus plasma concentration curve (AUC)
Time frame: 0 ~ 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.